YU216778A - Process for producing imidazole derivatives - Google Patents

Process for producing imidazole derivatives

Info

Publication number
YU216778A
YU216778A YU02167/78A YU216778A YU216778A YU 216778 A YU216778 A YU 216778A YU 02167/78 A YU02167/78 A YU 02167/78A YU 216778 A YU216778 A YU 216778A YU 216778 A YU216778 A YU 216778A
Authority
YU
Yugoslavia
Prior art keywords
imidazole derivatives
producing imidazole
producing
derivatives
imidazole
Prior art date
Application number
YU02167/78A
Other languages
English (en)
Inventor
A Krasso
P E Kriebs
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of YU216778A publication Critical patent/YU216778A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU02167/78A 1977-09-19 1978-09-14 Process for producing imidazole derivatives YU216778A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU78140 1977-09-19
CH814978 1978-07-28

Publications (1)

Publication Number Publication Date
YU216778A true YU216778A (en) 1983-01-21

Family

ID=25702876

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02167/78A YU216778A (en) 1977-09-19 1978-09-14 Process for producing imidazole derivatives

Country Status (36)

Country Link
US (2) US4182766A (es)
EP (1) EP0001279B1 (es)
JP (1) JPS5459274A (es)
AR (1) AR224350A1 (es)
AT (1) AT368152B (es)
AU (1) AU519711B2 (es)
BG (1) BG28708A3 (es)
BR (1) BR7806148A (es)
CA (1) CA1106849A (es)
DD (1) DD138210A5 (es)
DE (2) DE2861237D1 (es)
DK (1) DK406578A (es)
EG (1) EG13530A (es)
ES (1) ES473451A1 (es)
FI (1) FI64365C (es)
FR (1) FR2403340A1 (es)
GB (1) GB2004281B (es)
GR (1) GR73069B (es)
HU (1) HU176111B (es)
IE (1) IE47363B1 (es)
IL (1) IL55557A (es)
IN (1) IN148930B (es)
IT (1) IT1098858B (es)
MC (1) MC1213A1 (es)
MT (1) MTP835B (es)
NL (1) NL7809529A (es)
NO (1) NO149962C (es)
NZ (1) NZ188405A (es)
OA (1) OA06054A (es)
PH (1) PH16342A (es)
PL (1) PL114494B1 (es)
PT (1) PT68573A (es)
RO (1) RO75258A (es)
SE (1) SE7809792L (es)
SU (1) SU793390A3 (es)
YU (1) YU216778A (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4321372A (en) * 1980-06-16 1982-03-23 Pfizer Inc. Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
IL66340A (en) * 1981-08-13 1986-08-31 Haessle Ab Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
HU193408B (en) * 1983-05-03 1987-10-28 Byk Gulden Lomberg Chem Fqb Process for production of new tree-cycle compounds
ZW4585A1 (en) * 1984-04-19 1985-11-20 Hoffmann La Roche Imidazole derivatives
DE3585252D1 (de) * 1984-07-06 1992-03-05 Fisons Plc Benzimidazole, und verfahren zu deren herstellung, deren formulierung und verwendung als magensaeuresekretionshemmende verbindungen.
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
EP0204215B1 (en) 1985-05-24 1993-08-11 G.D. Searle & Co. 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines
US5869513A (en) * 1985-05-24 1999-02-09 G. D. Searle & Co. 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
SE8600658D0 (sv) * 1986-02-14 1986-02-14 Haessle Ab Novel composition of matter
US4687775A (en) * 1986-07-17 1987-08-18 G. D. Searle & Co. 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4721718A (en) * 1986-08-18 1988-01-26 G. D. Searle & Co. 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
SE8604998D0 (sv) 1986-11-21 1986-11-21 Haessle Ab Novel pharmacological compounds
NZ234564A (en) 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
DE3701277A1 (de) * 1987-01-17 1988-07-28 Boehringer Mannheim Gmbh Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
SE8804629D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
IE64199B1 (en) * 1988-12-22 1995-07-12 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804628D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New compounds
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5049674A (en) 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
WO1994001107A1 (en) * 1992-07-08 1994-01-20 Monsanto Company Benzimidazoles for alleviating stomach ulcers in swine
WO1995029897A1 (en) 1994-04-29 1995-11-09 G.D. Searle & Co. METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
ATE262332T1 (de) * 1995-09-21 2004-04-15 Pharma Pass Ii Llc Lansoprazolhaltige arzneizusammensetzung und herstellungsverfahren
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
KR100463031B1 (ko) * 1997-05-26 2005-04-06 동아제약주식회사 5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
CA2517005A1 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005007115A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
AR045061A1 (es) * 2003-07-18 2005-10-12 Santarus Inc Formulacion farmaceutica y metodo para tratar trastornos gastrointestinales causados por acido
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) * 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
CA2665226C (en) 2006-10-05 2014-05-13 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985661A (en) * 1956-02-06 1961-05-23 American Cyanamid Co Preparation of 2(omicron-aminophenyl)-benzimidazole
GB1234058A (es) * 1968-10-21 1971-06-03
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen

Also Published As

Publication number Publication date
DK406578A (da) 1979-03-20
HU176111B (en) 1980-12-28
AR224350A1 (es) 1981-11-30
FI782847A (fi) 1979-03-20
DE2861237D1 (en) 1981-12-10
CA1106849A (en) 1981-08-11
ES473451A1 (es) 1979-05-01
PL209693A1 (pl) 1979-06-04
FI64365B (fi) 1983-07-29
EP0001279B1 (de) 1981-09-30
NO149962C (no) 1984-07-25
NL7809529A (nl) 1979-03-21
GR73069B (es) 1984-01-30
ATA673378A (de) 1982-01-15
IL55557A0 (en) 1978-12-17
US4182766A (en) 1980-01-08
AU3981778A (en) 1980-03-20
IN148930B (es) 1981-07-25
IT1098858B (it) 1985-09-18
BG28708A3 (en) 1980-06-16
SE7809792L (sv) 1979-03-20
EG13530A (en) 1981-12-31
IT7827861A0 (it) 1978-09-19
IE781878L (en) 1979-03-19
RO75258A (ro) 1980-11-30
NZ188405A (en) 1981-03-16
PH16342A (en) 1983-09-05
GB2004281B (en) 1982-03-10
FR2403340B1 (es) 1981-02-13
MTP835B (en) 1979-11-14
DE2840591A1 (de) 1979-03-29
FR2403340A1 (fr) 1979-04-13
MC1213A1 (fr) 1979-05-18
US4248880A (en) 1981-02-03
SU793390A3 (ru) 1980-12-30
NO783155L (no) 1979-03-20
OA06054A (fr) 1981-06-30
IE47363B1 (en) 1984-03-07
GB2004281A (en) 1979-03-28
PL114494B1 (en) 1981-01-31
PT68573A (fr) 1978-10-01
IL55557A (en) 1982-02-28
AT368152B (de) 1982-09-27
DD138210A5 (de) 1979-10-17
FI64365C (fi) 1983-11-10
JPS5459274A (en) 1979-05-12
BR7806148A (pt) 1979-04-17
AU519711B2 (en) 1981-12-17
NO149962B (no) 1984-04-16
EP0001279A1 (de) 1979-04-04

Similar Documents

Publication Publication Date Title
YU216778A (en) Process for producing imidazole derivatives
HU179066B (en) Process for producing citostatic solysaccharide derivatives
HU179983B (en) Process for preparing nitroimidazole derivatives
HU177718B (en) Process for preparing hydantoin derivatives
HU174845B (hu) Sposob poluchenija proizvodnykh merkapto-alkil-sul'fonil-prolinov
YU199478A (en) Process for preparing triphenylalkene derivatives
CS194833B2 (en) Process for preparing azoles
YU233478A (en) Process for producing new pyrrole derivatives
HU175471B (hu) Sposob poluchenija novykh proizvodnykh 3-skobka-1-pirazolil-skobka zakryta-piridazina
HU177287B (en) Process for producing pyrimidyl-aminoalkylether derivatives
HU177857B (en) Process for producing tetrasole derivatives
PT67615B (en) Process for preparing oxadiazolopyrimidine derivatives
HU177722B (en) Process for preparing 14-amino-morfine derivatives
PT67614B (en) Process for preparing oxadiazolopyrimidine derivatives
HU175783B (hu) Sposob poluchenija proizvodnykh benzo-quadratnaja skobka-d-quadratnaja skobka zakryta tiazolov
HU178211B (en) Process for producing new imidazol derivatives
HU178360B (en) Process for producing 3-bracket-tetrasol-5yl-bracket closed-1-azaxantone derivatives
GB1537867A (en) Process for preparing 4-acylamino-piperidine derivatives
HU178247B (en) Process for preparing benzolsulphonyl-carbamide derivatives
HU179345B (en) Process for producing 17-alpha-bracket-3-hydroxy-propyl-bracket closed-17-beta-hydroxy-4-androsten-3-one derivatives
HU179711B (en) Process for preparing steroid-spiro-oxazolidinone derivatives
HU178804B (en) Process for preparing 1-hidroxy-aporphine derivatives
PT67635B (en) Process for preparing everninomicin derivatives
HU175028B (hu) Sposob poluchenija proizvodnykh 17-al'fa-alkinil-androst-4-enov
PT67276B (en) Process for preparing imidazole derivatives